21 June 2021 - 08:00-12:00

1: Acute stroke: is there a large vessel occlusion? Is there a >50% carotid stenosis?
Jurgita Valaikienė, Vilnius, Lithuania

2: Headache: is there giant-cell arteritis? Pulsatile tinnitus: is there a dural fistula?
Elsa Azevedo, Porto, Portugal

3: Ophthalmic neuro-POCUS: is there a central retina artery occlusion? Is there intracranial hypertension?
Piergiorgio Lochner, Saarland, Germany

1: Improving clinical diagnosis of migraine
Raquel Gil-Gouveia, Lisbon, Portugal

2: Advances in Genetics for migraine diagnosis
Nadine Pelzer, Leiden, The Netherlands

3: Diagnostic biomarkers for migraine
Pablo Irimia Sieria, Pamploma, Spain

1: Potential of gene editing for neurological diseases
Nicole Déglon, Lausanne, Switzerland  

2: Antisense-oligonucleotide
Frank Bennett, California, USA

3: Gene Therapy
Petra Kaufmann, Washington, USA

1: Epidemiology and disease characteristics of late-onset Multiple Sclerosis
Melinda Magyari, Copenhagen, Denmark

2: Treatment response to disease modifying therapies in elderly MS patients
Maria Trojano, Policlinico, Italy

3: Immunosenescence and the risk of disease modifying therapies in Multiple Sclerosis
Matthias Mehling, Basel, Switzerland

1: Precision Medicine for Parkinson’s Disease
Oliver Bandmann, Sheffield, United Kingdom

2: Device Aided Therapies for Movement Disorders
Regina Katzenschlager, Vienna, Austria

3: Update on Developments in Digital Devices for Monitoring of Movement Disorders
Alvaro Sanchez-Ferro, Mostoles, Spain

1: Imaging anatomy: neuroradiological approach
Mario Muto, Naples, Italy

2: Infectious and inflammatory diseases
Alex Rovira, Barcelona, Spain

3: Vascular disorders
Majda Thurnher, Vienna, Austria

1: The role of early genetic diagnostic in the management of patients living with NMDs
Teresinha Evangelista, Paris, France

2: Digital health technologies in the diagnosis of NMDs
Jordi Diaz Manera, New Castle, United Kingdom

3: Robotic rehabilitation in neuromuscular disorders
Gabriele Siciliano, Pisa, Italy

1: Treatable Neurometabolic Diseases
Barbara Plecko, Graz, Austria

2: Lysosomal Storage Diseases: new treatments and related issues
Alessandro Simonati, Verona, Italy

3: Diagnostic Tools in Neurometabolic Diseases: a Multifaceted Approach
Nicole Wolf, Amsterdam, The Netherlands

1: The characteristics of cognitive impairment in DLB and PDD
Roberta Biundo, Venice, Italy

2: Nuclear medicine probes of cognitive impairment in early Parkinson’s disease
Flavio Nobili, Genoa, Italy

3: Therapeutic approaches to cognitive impairment in PDD and DLB
Javier Pagonabarraga, Barcelona, Spain

1: Alois Alzheimer and the group of great reputation
Hans Förstl, Munich, Germany

2: Arnold Pick, life for neurology and neuropathology
Evzen Ruzicka, Prague, Czech Republic

3: Examined by a neuropathologist - from today's point of view
Tom Warner, London, United Kingdom

TBA

1: What to do before starting to write an article?
Claudia Sommer, Würzburg, Germany

2: The different sections of a manuscript
Michael Strupp, Munich, Germany

3: How to write a good abstract?
Karin Klijn, Nijmegen, The Netherlands

4: How handle editors and reviewers’ comments?
Didier Leys, Lille, France

1: Epidemiology meets deep learning and artificial intelligence
Mihaela van der Schaar, Cambridge, United Kingdom

2: Current and future use of precise tools (e.g. genetics, biomarkers, imaging) for personalised diagnosis and prognosis
Henrik Zetterberg, London, United Kingdom

3: Individual treatment decisions based on precision neurology
Francesco Muntoni, London, United Kingdom

4: Precision Medicine without limits? Ethical and economic challenges
Christiane Druml, Vienna, Austria